Purpose/Objectives: Sleep-related breathing disorders (SRBDs), including obstructive sleep apnea and central sleep apnea, are common among patients with cardiovascular disease (CVD), but clinicians often do not pay enough attention to SRBDs. The purpose of this narrative review is to update advanced practice registered nurses on the literature focusing on the relationship between SRBDs and CVD (eg, hypertension, heart failure, coronary artery disease, arrhythmias, and stroke) and on treatments that can improve SRBDs in patients with CVD.
Description of the Project:
We conducted an electronic search of the literature published between 1980 and 2016 from PubMed, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Academic Search Premier, and related health resource Web sites to address the aims of this study. Outcomes: Fifty-six primary research articles (42 observational studies and 14 experimental and quasi-experimental studies) were selected based on our study aims and inclusion criteria. The studies revealed that individuals with CVD are at a greater risk for SRBDs and that SRBDs can worsen CVD. The findings from the studies also suggest that positive airway treatment could improve both SRBDs and CVD.
Conclusions:
This review found a close relationship between SRBDs and CVD. Advanced practice registered nurses are in key positions to identify and help patients manage SRBDs. In particular, advanced practice registered nurses can educate staff and establish standards of practice to improve outcomes for patients with CVD. KEY WORDS: advanced practice registered nurses, apnea syndromes, cardiovascular diseases C ardiovascular disease (CVD) is the leading cause of death in the United States 1 ; 1 in every 4 deaths is due to CVD. Approximately 7% of the US population is reported to have some type of CVD including coronary heart disease, heart failure, arrhythmias, venous or artery disease, valvular heart disease, stroke, and congenital heart disease. 2 Clinicians are aware of the common risk factors for CVD, such as family history, high cholesterol level, high blood pressure, diabetes, and metabolic syndrome. 2 Sleep-related breathing disorders (SRBDs) can interfere with normal cardiovascular homeostasis and are common among individuals with CVD. 3 However, many clinicians lack an accurate understanding of the relationship between SRBDs and CVD. 4 Sleep-related breathing disorder is an overarching term used to describe pauses in breathing and a decrease in the number of ventilations during sleep, which can result in negative consequences such as excessive daytime sleepiness, cognitive impairment, mood disturbance, functional decline, and worsening quality of life. 5 It includes obstructive sleep apnea (OSA), central sleep apnea (CSA), and sleep-related hypoventilation and hypoxemic syndromes. 6 In this article, we focus on OSA and CSA, the most studied in SRBD research. Obstructive sleep apnea is characterized by a crowded or completely obstructed upper airway during sleep, leading to partial (hypopnea) or complete (apnea) obstruction of airflow, lasting for 10 or more seconds. The ratio of apnea and hypopnea events per hour is referred to as the apnea-hypopnea index (AHI). The AHI reflects the severity of the obstruction: AHI of 5 to 15 (mild), 16 to 30 (moderate), and greater than 30 (severe). Among research studies, individual AHI values may vary; therefore, the terms mild, moderate, and severe are defined by individual studies. 7 Higher AHIs are associated with greater cardiovascular comorbidity, particularly if the AHIs are associated with significant oxygen desaturation. 8, 9 The clinical presentation of OSA includes disruptive snoring, witnessed apnea or gasping, and daytime sleepiness. 10 Unlike OSA, CSA is characterized by cessation of breathing during sleep due to loss of respiratory drive. 7 In CSA, pauses in breathing are associated with no respiratory effort. Apnea in individuals with CSA is often characterized by a crescendo-decrescendo pattern of breathing referred to as Cheyne-Stokes, with nocturnal dyspnea, witnessed apnea, fatigue, and daytime sleepiness. Central sleep apnea is defined as more than 5 apnea events per hour of sleep, lasting for 10 or more seconds, with the presence of frequent arousals during sleep or hypersomnolence during the day. 7,10 Central sleep apnea is less common than OSA, but it is present more often in older men with heart failure, neurologic disorders, mitral regurgitation, and atrial fibrillation. 7, 10 Individuals with CSA may also have coexisting OSA, referred to as mixed apnea. A diagnosis of CSA requires that at least 50% of all the apneic events be central apnea.
Findings from large epidemiological studies, such as the Sleep Heart Health Study and Wisconsin Sleep Cohort Study, support clear connections between SRBDs and CVD because there is a high prevalence of SRBDs in patients with CVD. Untreated SRBDs are associated with an increased mortality risk, even after controlling for common confounders such as age, sex, and body mass index. 11 Untreated SRBDs increase an individual's risk for cardiovascular complications. 10 Repetitive hypoxia, due to pauses in breathing and partial ventilation, affects individuals' sleep and daytime function, as well as cardiovascular homeostasis. 7 Intermittent hypoxia can negatively affect cardiovascular endothelial function, myocardial contractility, and oxidative stress, producing systemic inflammation and reduced function of the cardiovascular system. 12 For individuals with mild SRBDs and CVD, initial treatment consists of lifestyle modification and optimized CVD management. 7, 8 For those who have moderate to severe SRBDs, several varieties of positive airway pressure (PAP) therapy are considered: continuous PAP (CPAP), bi-level PAP, and adaptive servo-ventilation (ASV). Selection is based upon the specific ventilatory needs of the patient. Continuous PAP uses a consistent level of air pressure to maintain an open airway during inspiration and expiration. Bi-level PAP delivers 2 different (preset) levels of continuous airway pressure, keeping the airway open during inspiration and reducing the pressure during expiration. It has been effective for conditions in which less pressure is needed during exhalation. Adaptive servo-ventilation devices adjust air pressure to ensure consistent ventilation. Ventilation is generated when there are pauses in breathing and ventilatory pressure is reduced during a normal patient-initiated breath. Adaptive servo-ventilation has been an option for treating CSA in individuals with heart failure resistant to other PAP therapies. 12, 13 Limited awareness of the link between SRBDs and CVD may result in underrecognition of SRBDs by healthcare providers among individuals with CVD. In general, SRBDs occur in approximately 5% of adults. 14 Among individuals with CVD, the rate of SRBDs is considerably higher (47%Y83%). 15Y18 It is estimated that 93% of women and 82% of men with moderate to severe SRBDs have not been given a diagnosis, even in populations that have medical access to sleep clinics. 19 Given that SRBDs are greatly underrecognized, advanced practice registered nurses (APRNs) can play a key role in early diagnosis and successful management of SRBDs and improve health outcomes of individuals with CVD. 20 Advanced practice registered nurses can establish systems to identify individuals who are at risk and facilitate accurate diagnosis and management. Advanced practice registered nurses can ensure that men and women are adequately screened and, perhaps most importantly, help individuals successfully manage SRBDs. Awareness of the strong relationship between SRBDs and CVD will help APRNs to understand the associated risks, screening recommendations, and appropriate interventions and to apply this knowledge in their practices.
Much research has been done to describe, explain, and predict the relationships between SRBDs and CVD in medicine and epidemiology. The purpose of this narrative review 21 is to inform APRNs of the key connections between SRBDs and CVD and raise awareness of the issues. We conducted a narrative literature review to provide readers with a foundation for understanding current knowledge and to identify implications for practice and research. 21 Our specific aims are to update APRNs on the literature that focuses both on (1) how SRBDs and CVD (ie, hypertension, heart failure, coronary artery disease, arrhythmias, and stroke) are related and (2) treatments that can improve SRBDs in patients with CVD. Articles were included if they met the following inclusion criteria: published, peer-reviewed, cross-sectional, longitudinal, experimental studies of human subjects that addressed both SRBDs and CVD. We excluded qualitative studies, editorials, book chapters, dissertations, commentaries, letters to the editor, and studies focusing on infants, children, or adolescents. The most common reason for these exclusions was that the studies focused on either SRBDs or CVD, not both. After a review of the 1039 remaining abstracts, articles, and their reference lists from the search, we excluded 860 articles that were not related to our aims. After retrieving the full-length articles, we assessed 188 full-text articles to assess for quality of evidence and rated the evidence as low, moderate, and high, with guidance from the Agency for Healthcare Research and Quality. 22 
METHODS Data Sources and Search Strategy

RESULTS
The final selection included 56 articles, 42 observational studies and 14 experimental and quasi-experimental studies, that met our inclusion criteria. Tables 1 to 6 include summaries of the articles synthesized for this article. Ten articles were related to SRBDs and hypertension, 23Y31,72 10 articles were related to SRBDs and heart failure, 18,32Y40 9 articles were related to SRBDs and coronary artery disease, 34, 35 ,41Y47 6 articles were related to SRBDs and arrhythmia, 48Y53 7 articles were related to SRBDs and stroke, 28,54Y59,73 and 14 articles were related to treatment options for patients who had SRBDs and CVD. 12,13,60Y71 Hypertension and SRBDs The findings from large cohort studies 23Y27, 30, 72 and clinical studies 28, 29, 31 have revealed strong associations between OSA and hypertension ( Table 1) . Researchers have investigated how OSA and hypertension are related. In cross-sectional studies using large population data, an increase in AHI and the category of higher AHI had higher odds of hypertension than those with lower AHI, even after controlling for possible covariates. 26, 27, 72 Furthermore, individuals with OSA were found to have higher blood pressure than those without it. For instance, Hla et al 25 found that the mean blood pressure was higher in the OSA group than in the control group (P G .05). Davies and colleagues 28 also found that the OSA group had significantly higher systolic and diastolic pressures during the day and night than the non-OSA group (P G .05).
A longitudinal study using data from the Wisconsin Sleep Cohort Study also revealed that an increase in AHI and higher AHI (eg, Q5) were associated with the development of hypertension. 23 Not only AHI during overall sleep stage but also AHI during rapid eye movement sleep were found to be related to the development of hypertension (P = .017). 24 
Heart Failure and SRBDs
There is a strong relationship between SRBDs and heart failure. Table 2 presents a summary of the articles that examined the relationship between SRBDs and heart failure. The findings revealed that the prevalence of SRBDs in patients with heart failure is high, and individuals with SRBDs have a higher risk of developing heart failure than those without SRBDs. 18, 32, 34, 36 Up to 53% of individuals with heart failure have OSA, and up to 21% have CSA, depending upon the population studied. 18, 32, 36 Severe SRBDs increase the risk of developing heart failure. 35 Findings from a well-known longitudinal study, the Sleep Heart Health Study, 34 demonstrated that individuals with severe OSA were 58% more likely to develop heart failure than those without OSA.
Not only do SRBDs and heart failure coexist frequently, but the coexistence of SRBDs and heart failure can also be detrimental to the progression of heart disease and health conditions. For instance, SRBDs are associated with negative functional outcomes in individuals with heart failure, 38 an increase in fluid accumulations, 37 reductions in left ventricular ejection fraction, alterations in blood gases, increased sympathetic activity, 74 impaired cognition, 39 lower exercise capacity, 40 worsened quality of life, 75 and increased mortality. 33 Coronary Artery Disease and SRBDs Individuals with SRBDs are at an increased risk of having and developing coronary artery disease, and individuals with coronary artery disease are at an increased risk of having SRBDs, based on the findings of several crosssectional 35,42Y46 and longitudinal studies 34, 41, 47 using large population-based cohorts. Table 3 presents a summary of the articles related to SRBDs and coronary artery disease.
In the cross-sectional studies, up to two-thirds of individuals with coronary artery disease were found to have SRBDs, and investigators found that increases in AHI were related to increases in the risk of developing coronary artery disease (odds ratios, 3.1 and 8.7). 44, 45 Individuals with untreated severe SRBDs were 2.6 times more likely to develop coronary artery disease or have an incident of heart failure compared with those without SRBDs. 47 The findings from a longitudinal study also demonstrated that greater AHI was associated with an increased risk of developing coronary artery disease. 34 Sleep-related breathing disorders were also related to poor health outcomes in individuals with coronary artery disease. A study using the Sleep Heart Health Study data revealed that SRBDs were associated with mortality from all causes and mortality from coronary artery disease, especially in men between ages 40 and 70 years (hazard ratio, 2.09). 41 Furthermore, Saito and colleagues 42 found that apneic episodes were related to arrhythmias among 49 individuals with previous myocardial infarctions.
Arrhythmias and SRBDs
The findings from the cross-sectional and longitudinal sleep studies 48Y53 demonstrated a connection between SRBDs and atrial and ventricular cardiac arrhythmias. Table 4 presents a summary of articles that explored the relationship between arrhythmia and SRBDs. In the Sleep Heart Heath Study, 49 individuals with SRBDs were 5 times more likely to have atrial fibrillation (P = .003) and ventricular arrhythmias (P = .004) than those without SRBDs. In a retrospective cohort study using longitudinal data from 3542 adults, OSA was found to be a significant risk factor for developing atrial fibrillation (hazard ratio, 2.18). 50 The results from a large population study showed that the incident of atrial fibrillation was higher in individuals with SRBDs compared with those without (1.36 vs 0.76). 53 In addition, researchers have found that greater AHI values were associated with bradyarrhythmias. 51 
Stroke and SRBDs
The findings from the epidemiological and clinical studies demonstrated that individuals with SRBDs have an increased risk of developing a stroke. 28 ,54Y59, 73 We summarized observational studies examining stroke and SRBDs in Table 5 . The studies revealed that individuals with OSA have higher risks of developing strokes.
The findings from a longitudinal study in which researchers used the Sleep Heart Healthy Study data revealed that increases in AHI were related to a higher risk of developing stroke in men, but not in women (P = .016). 56 Yaggi et al 54 examined longitudinal data and reported that individuals with OSA had greater than a 2-fold risk of developing subsequent strokes than did those without OSA (hazard ratio, 2.24). Furthermore, individuals in a higher AHI quartile had an increase in the hazard ratio of stroke. 56 In a cross-sectional study by Davies and colleagues, 28 individuals with OSA had a 17% higher rate of developing cerebrovascular pathology (detectable with magnetic resonance imaging) than those without OSA.
In addition to high rates of OSA among patients with stroke, the presence of OSA among patients with stroke is related to poorer functional outcomes than patients with stroke without OSA. 59 Furthermore, higher AHI could worsen the health outcomes of patients with stroke. 58 
Treatment of SRBDs in CVD
Studies show that PAP therapy can decrease the severity of SRBDs. The effectiveness of long-term PAP therapy and other treatment strategies has been tested in some patients with CVD but not all. Table 6 shows the results from the experimental and quasi-experimental studies investigating treatments of SRBDs in patients with CVD. Among a variety of PAP therapies, CPAP is the most studied in patients with CVD. For individuals with hypertension, the use of CPAP has demonstrated a modest reduction in blood pressure 60, 61 ; individuals with more severe SRBDs with resistant hypertension have demonstrated a greater reduction in blood pressure. 64, 67 For individuals with heart failure, optimizing heart failure pharmacological treatment, 68 exercise programs, 63, 65 and the elimination of alcohol and sedatives that cause pharyngeal collapse during sleep are effective approaches to prevent the onset of OSA. 10 Positive airway pressure was found to improve nocturnal oxygenation, reduce left ventricular afterload, and increase the left ventricular ejection fraction. 62 Researchers have suggested that ASV is an option for treating CSA in individuals with heart failure who are resistant to other PAP therapies. 12, 13 However, Cowie et al 66 reported higher mortality rates in those using ASV, raising questions about the safety of this therapy.
For individuals with coronary artery disease and SRBDs, the research studies indicated that CPAP is the most common treatment option. 69, 70 In individuals with arrhythmia, treating SRBDs had a positive effect on arrhythmia. For instance, the recurrence of atrial fibrillation 1 year after cardioversion was found to be significantly lower in individuals with PAP-treated OSA than in those without treatment of OSA. 71 Positive airway pressure has been demonstrated as effective in individuals who have experienced a stroke, but the findings indicate that patients with stroke have a low PAP adherence rate. 76 
DISCUSSION
In this review, we found that SRBDs are related to various types of CVD, which include hypertension, heart failure, coronary artery disease, arrhythmia, and stroke. In cross-sectional studies included in this review, the prevalence of SRBDs among individuals with CVD was high, and CVD was prevalent among individuals with SRBDs. In longitudinal studies, the presence of CVD could increase the development of SRBDs, or underlying SRBDs could increase the development of CVD. These results imply that the 2 conditions might precipitate each other. Among the various treatment modalities, PAP therapy has been the most studied and has been shown to be effective in patients with CVD and SRBDs. Although PAP therapy needs to be further tested, using PAP therapy could not only improve SRBDs but also improve CVD outcomes.
Our narrative review reveals that SRBDs and CVD are closely related. Both the cross-sectional and longitudinal studies indicate that the presence and severity of SRBDs are related to the risk and progression of CVD. This link could be explained by 3 mechanisms: (1) nighttime hypoxemia, (2) large negative changes in intrathoracic pressure, and (3) frequent nighttime awakenings. 5, 10 First, partial or full airway obstruction during sleep reduces oxygen saturation causing intermittent hypoxemia. The hypoxemia reduces oxygen delivery to the myocardium and indirectly affects endothelial cell function, pulmonary arteriolar vasoconstriction, and sympathetic nervous system activation.
Second, during obstructive apneic events, large negative intrathoracic pressure can be induced. During CSA, hyperpnea (an increase in the depth of respiration to meet metabolic demands) can induce large, negative pressure deflation especially in the compromised lungs often found in patients with heart failure. These changes in pleural pressure are more pronounced in OSA than in CSA. An increase in intrathoracic pressure can increase myocardial oxygen consumption and extravascular lung fluid volume, which is closely related to pulmonary edema in patients with heart failure. Right ventricular filling can increase because of increased intrathoracic pressure, resulting in a decreased left ventricular compliance and volume. Fluctuations in pleural pressure contribute to changes in right and left ventricular preload and afterload, as well as increased lung pressure from increased transmural pressure of the right and left ventricles and the pulmonary microvascular bed.
Third, individuals with SRBDs lose the essential restorative effects of sleep on the cardiovascular system because of nighttime arousals. Arousals generated from airway obstruction can contribute to significant surges in blood pressure and heart rate through the night in individuals Continued with OSA. In CSA, individuals could wake up at the peak of hyperventilation. These awakenings from sleep are caused by increases in sympathetic activity and decreases in parasympathetic nervous system activity resulting in higher blood pressure and heart rate. The changes in sympathetic and parasympathetic nervous system activities can lead to an increase in systemic vascular resistance and left ventricular afterload, vasoconstriction with increased blood pressure, right ventricular preload, increased myocardial contractility, endothelial dysfunction, systemic inflammation, hypertrophy, tachycardia, and arrhythmias. 5, 10 Research suggests that PAP therapy is the most effective treatment for individuals with CVD and SRBDs. Among PAP therapies, CPAP was the most studied and revealed its effectiveness in reviewed articles. However, PAP therapy is not tested in all the CVD samples, and some are tested in a poor manner. More randomized controlled trials are needed to demonstrate the efficacy of PAP on each type of CVD. Proper treatment and management of SRBDs could improve symptoms of SRBDs including AHI, arousals, and oxygen saturation and health outcomes such as exercise capacity, ejection fraction, cardiovascular symptoms, hospitalizations, and quality of life. Continuous PAP has been effective for individuals with hypertension, heart failure, coronary artery disease, arrhythmia, and stroke. One surprising finding was the questionable effects of ASV in patients with heart failure, contradicting previous treatment recommendations. 12 Adaptive servoventilation was found to increase mortality rates. Clinicians need to be aware of this result and be cautious when selecting ASV for patients with heart failure.
Implications for Practice
Individuals with CVD are at a greater risk for SRBDs, and those with SRBDs are at a greater risk for CVD sequelae. Therefore, early identification and successful management of SRBDs are essential to maintain cardiovascular health and improve SRBD symptoms. Early screening and diagnosis are important because, too often, clinicians are unaware of the prevalence of SRBDs among patients with CVD. Lack of screening will delay the treatment of these coexisting conditions and increase the negative consequences. Advanced practice registered nurses play key roles in preventing, screening, and managing individuals with SRBDs and educating patients and other healthcare providers.
First, APRNs can screen patients with CVD by asking brief screening questions or administering standard questionnaires to evaluate the risk of SRBDs during outpatient visits. During hospitalization, APRNs can increase the awareness of undiagnosed SRBDs by screening and observing for SRBD symptoms, such as snoring, gasping, pauses in breathing, fatigue, and excessive daytime sleepiness. Second, APRNs can play a pivotal role in successful Abbreviations: AF, atrial fibrillation; AHI, apnea-hypopnea index; ASV, adaptive servo-ventilation; BP, blood pressure; CAD, coronary artery disease; CPAP, continuous positive airway pressure; CVD, cardiovascular disease; HF, heart failure; OSA, obstructive sleep apnea; PSG, polysomnography.
Clinical Nurse Specialist A www.cns-journal.com long-term management of SRBDs by working collaboratively with individuals to identify barriers and develop new management strategies to evaluate and support PAP adherence, weight management, and provider follow-ups. 77Y81 Third, evaluating and acknowledging worsening cardiovascular symptoms (eg, fluid accumulations, lower ejection fraction, and changes in blood gases) and cognitive and functional decline are important for individuals who have both SRBDs and CVD. Sleep-related breathing disorders can influence both heart health and other symptoms of patients with CVD, such as impaired memory and problem solving 39 or decreases in exercise capacity. 40 Recognition of these symptoms may improve health outcomes among patients with CVD with SRBDs. Finally, APRNs can facilitate educational offerings regarding the importance of early identification and continued management of SRBDs for other healthcare team members to encourage early diagnosis and treatment.
Implications for Research
To date, most of the research relative to this topic has focused on improving PAP adherence in general and is not specific to the needs of those with CVDs. The higher rates of SRBDs in CVD, the number of associated conditions, and the unique presentation of individuals with heart failure suggest that assessment and long-term management for this population may present unique challenges that need to be investigated: CVD-specific assessment and screening methods, as well as strategies to address PAP adherence unique to individuals with CVD. In addition, more intervention studies are needed to evaluate the treatment efficacy of PAP therapy in particular CVDs. Interventions led by APRNs could reduce the negative consequences from SRBDs in CVD and may reduce the rate and progression of CVD and thereby improve patients' quality of life.
SUMMARY
We have reviewed the literature related to SRBDs in CVD and demonstrated a close link between SRBDs and CVD. Advanced practice registered nurses can play a key role in screening and managing individuals with SRBDs. In particular, APRNs can educate staff and establish standards of practice to improve CVD outcomes for patients. Proper screening and management of SRBDs may maintain cardiovascular health and improve symptoms, thereby improving quality of life among individuals with CVD.
